キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/02/10 | 2,306 | 2,306 | 2,272 | 2,282 | -25 | -1.1% | 38,800 |
2021/02/09 | 2,326 | 2,336 | 2,290 | 2,307 | -44 | -1.9% | 64,200 |
2021/02/08 | 2,312 | 2,355 | 2,299 | 2,351 | +41 | +1.8% | 80,300 |
2021/02/05 | 2,300 | 2,317 | 2,276 | 2,310 | +29 | +1.3% | 80,900 |
2021/02/04 | 2,280 | 2,302 | 2,253 | 2,281 | -3 | -0.1% | 57,800 |
2021/02/03 | 2,283 | 2,295 | 2,262 | 2,284 | -28 | -1.2% | 78,700 |
2021/02/02 | 2,355 | 2,355 | 2,283 | 2,312 | +3 | +0.1% | 124,700 |
2021/02/01 | 2,307 | 2,338 | 2,292 | 2,309 | +4 | +0.2% | 87,600 |
2021/01/29 | 2,287 | 2,339 | 2,281 | 2,305 | +4 | +0.2% | 120,500 |
2021/01/28 | 2,274 | 2,324 | 2,263 | 2,301 | -3 | -0.1% | 120,600 |
2021/01/27 | 2,252 | 2,312 | 2,251 | 2,304 | +64 | +2.9% | 90,600 |
2021/01/26 | 2,234 | 2,240 | 2,218 | 2,240 | +12 | +0.5% | 140,900 |
2021/01/25 | 2,225 | 2,238 | 2,212 | 2,228 | +15 | +0.7% | 95,200 |
2021/01/22 | 2,249 | 2,257 | 2,213 | 2,213 | -61 | -2.7% | 94,000 |
2021/01/21 | 2,268 | 2,308 | 2,268 | 2,274 | +6 | +0.3% | 72,200 |
2021/01/20 | 2,261 | 2,275 | 2,235 | 2,268 | +25 | +1.1% | 50,700 |
2021/01/19 | 2,275 | 2,290 | 2,242 | 2,243 | -48 | -2.1% | 62,800 |
2021/01/18 | 2,290 | 2,302 | 2,274 | 2,291 | -6 | -0.3% | 38,500 |
2021/01/15 | 2,339 | 2,345 | 2,297 | 2,297 | -45 | -1.9% | 78,600 |
2021/01/14 | 2,302 | 2,367 | 2,275 | 2,342 | +74 | +3.3% | 112,000 |
2021/01/13 | 2,300 | 2,306 | 2,249 | 2,268 | -50 | -2.2% | 87,300 |
2021/01/12 | 2,288 | 2,333 | 2,282 | 2,318 | +48 | +2.1% | 97,400 |
2021/01/08 | 2,236 | 2,279 | 2,235 | 2,270 | +49 | +2.2% | 87,000 |
2021/01/07 | 2,237 | 2,253 | 2,221 | 2,221 | +10 | +0.5% | 85,500 |
2021/01/06 | 2,168 | 2,238 | 2,168 | 2,211 | +47 | +2.2% | 99,000 |
2021/01/05 | 2,165 | 2,201 | 2,150 | 2,164 | -1 | ±0% | 81,800 |
2021/01/04 | 2,232 | 2,232 | 2,152 | 2,165 | -72 | -3.2% | 68,400 |
2020/12/30 | 2,282 | 2,282 | 2,229 | 2,237 | -43 | -1.9% | 122,000 |
2020/12/29 | 2,276 | 2,283 | 2,261 | 2,280 | +39 | +1.7% | 97,400 |
2020/12/28 | 2,229 | 2,245 | 2,217 | 2,241 | +6 | +0.3% | 71,700 |
2020/12/25 | 2,230 | 2,249 | 2,222 | 2,235 | +11 | +0.5% | 60,400 |
2020/12/24 | 2,198 | 2,230 | 2,191 | 2,224 | +35 | +1.6% | 76,300 |
2020/12/23 | 2,209 | 2,209 | 2,179 | 2,189 | -13 | -0.6% | 88,700 |
2020/12/22 | 2,205 | 2,214 | 2,198 | 2,202 | -12 | -0.5% | 88,400 |
2020/12/21 | 2,215 | 2,224 | 2,206 | 2,214 | -4 | -0.2% | 74,200 |
2020/12/18 | 2,221 | 2,227 | 2,207 | 2,218 | -10 | -0.4% | 172,900 |
2020/12/17 | 2,231 | 2,243 | 2,219 | 2,228 | +5 | +0.2% | 64,400 |
2020/12/16 | 2,255 | 2,255 | 2,207 | 2,223 | -27 | -1.2% | 87,800 |
2020/12/15 | 2,247 | 2,266 | 2,243 | 2,250 | +15 | +0.7% | 134,700 |
2020/12/14 | 2,198 | 2,246 | 2,193 | 2,235 | +38 | +1.7% | 96,100 |
2020/12/11 | 2,167 | 2,213 | 2,158 | 2,197 | +34 | +1.6% | 152,800 |
2020/12/10 | 2,154 | 2,171 | 2,150 | 2,163 | -9 | -0.4% | 54,600 |
2020/12/09 | 2,150 | 2,179 | 2,149 | 2,172 | +30 | +1.4% | 78,300 |
2020/12/08 | 2,089 | 2,152 | 2,072 | 2,142 | +42 | +2% | 103,200 |
2020/12/07 | 2,100 | 2,113 | 2,089 | 2,100 | +25 | +1.2% | 115,900 |
2020/12/04 | 2,086 | 2,099 | 2,055 | 2,075 | -34 | -1.6% | 180,600 |
2020/12/03 | 2,144 | 2,144 | 2,095 | 2,109 | -39 | -1.8% | 139,900 |
2020/12/02 | 2,194 | 2,197 | 2,142 | 2,148 | -31 | -1.4% | 169,400 |
2020/12/01 | 2,100 | 2,183 | 2,100 | 2,179 | +89 | +4.3% | 216,900 |
2020/11/30 | 2,115 | 2,115 | 2,084 | 2,090 | -35 | -1.6% | 165,800 |
1051~
1100
件表示中 / 3709件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 396,000円 | +3.6% | +6.1% | 3.03% | 13.34倍 | 0.79倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 405,500円 | +21.7% | +999.9% | 0.00% | 16.99倍 | 5.62倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
サワイGHD | 176,600円 | +5.9% | +24.5% | 3.11% | 11.72倍 | 1.10倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 381,100円 | -6.4% | -71.8% | 4.99% | 42.44倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム